Your Genes May Explain Why Your ADHD Medication Isn't Working. Now There's a Test for That.

▤ Summary

Springboard Clinic and Biron Health Group have partnered to offer pharmacogenomic DNA testing for ADHD treatment in Ontario. The test analyzes 51 genes and more than 100 psychiatric medications to help clinicians predict how patients may respond before prescribing. The offering aims to reduce trial-and-error prescribing, especially for patients with prior treatment failures or families reluctant to start medication. Springboard is integrating the test into its broader ADHD care model alongside assessment, coaching, therapy, and psychiatric support.

▦ Linked Companies